Redeye: Imint - Good growth prospects

Imint has signed several promising deals during the last months, where we especially value the recent agreements covering use of additional Vidhance features. Sales are, however, still on a low level and we have consequently revised our estimates, resulting in an updated fair value range.

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye – Research Powered Investment Banking.


We’re all about video enhancement

Book a Demo